News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Wegovy, which is a prescription medicine is indicated to help manage weight and lower the risk of serious heart-related ...
Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster ...
Wegovy is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults and children over 12 with obesity, defined as a body mass index (BMI) of 30 or higher, and ...